Loading...
Header Logo
Keywords
Last Name
Institution

Dr San Maurice Ouattara

TitleStudy physician, Sub-Investigator
InstitutionCentre national de recherche et de formation sur le paludisme (CNRFP)
DepartmentPublic health
Address1487, Avenue Koumda Yonré
Ouagadougou, 01 BP 2208 Ouaga 01
Burkina Faso
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    Diseases are undoubtedly a major factor of impoverishment in addition to sufferings and deaths that they impose. The underdevelopment and chronic poverty of Low and Middle Incomes Countries could not be controlled without providing effective and affordable responses to infectious or parasitic, endemic or epidemic diseases.
    Contributing by heath research to find these solutions is my longing and my commitment.
    I am a Medical Doctor, junior scientist in early career. Fellow of the EDCTP-WHO/TDR Clinical Research and Development Fellowships 2016. I have around five years’ experience in conducting clinical trials; trial patient selection, enrolment, follow up, safety reporting and patient health care.
    My topics of interest are Biostatistics, Epidemiology, Malaria and Infectious diseases


    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial. Lancet. 2018 04 07; 391(10128):1378-1390. PMID: 29606364.
      View in: PubMed
    2. Ouédraogo AL, Bastiaens GJ, Tiono AB, Guelbéogo WM, Kobylinski KC, Ouédraogo A, Barry A, Bougouma EC, Nebie I, Ouattara MS, Lanke KH, Fleckenstein L, Sauerwein RW, Slater HC, Churcher TS, Sirima SB, Drakeley C, Bousema T. Efficacy and safety of the mosquitocidal drug ivermectin to prevent malaria transmission after treatment: a double-blind, randomized, clinical trial. Clin Infect Dis. 2015 Feb 01; 60(3):357-65. PMID: 25414262.
      View in: PubMed
    Ouattara's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description